Lingling Tian, Editor of Therapeutic Advances in Medical Oncology at SAGE Publishing, shared a post on LinkedIn:
“Clinical Medicine Insights: Oncology – 2025 Year in Review
I began working with Clinical Medicine Insights: Oncology at the end of 2020, took a short leave in 2025, and have now returned – joined by George Vlachogiannis and Applonia Rose, PhD as Editors to help expand the journal’s scope and reach. This year the journal published a broad mix of reviews and original research papers spanning basic science, translational studies, and clinical relevance.
2025 by the numbers
Articles published: [60+]
Author countries represented: [20+]
Most‑read article:
– Adaptive Treatment of Metastatic Prostate Cancer Using Generative Artificial Intelligence
– Evaluating Patient Adherence and Persistence to Tyrosine-Kinase Inhibitors for Metastatic Renal Cell Carcinoma: A Retrospective Analysis of Real-World Data
– Potency and Safety of KRAS G12C Inhibitors in Solid Tumors: A Systematic Review
Thank you to our authors, reviewers, editorial board members, and readers. We look forward to new initiatives and broader collaborations in 2026. If you have research or reviews that bridge basic, translational, or clinical oncology, we welcome submissions for 2026.”
More posts featuring Lingling Tian on OncoDaily.